Plasma human neutrophil proteins-1, -2, and -3 levels in patients with bladder cancer

Journal of Cancer Research and Clinical Oncology

Volumn 139, Issue 2, 2013, Pages 195-199

  Gunes, Mustafa ^a   Gecit, Ilhan ^a   Pirincci, Necip ^a   Kemik, Ahu Sarbay ^b   Purisa, Sevim ^b   Ceylan, Kadir ^a   Aslan, Mehmet ^a  

^a YUZUNCU YIL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Bladder cancer; Clinicopathological parameters; Human neutrophil proteins 1, 2, and 3

Indexed keywords

ALPHA DEFENSIN; HUMAN NEUTROPHIL PROTEIN 1; HUMAN NEUTROPHIL PROTEIN 2; HUMAN NEUTROPHIL PROTEIN 3; UNCLASSIFIED DRUG; DEFENSIN 1; DEFENSIN 2; DEFENSIN 3; TUMOR MARKER;

ADULT; ARTICLE; BLADDER CANCER; CANCER GRADING; CANCER GROWTH; CANCER STAGING; CONTROLLED STUDY; DISTANT METASTASIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LYMPH NODE METASTASIS; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TUMOR INVASION; TUMOR VOLUME; BLADDER TUMOR; BLOOD; CASE CONTROL STUDY; DISEASE COURSE; MIDDLE AGED; PATHOLOGY;

ADULT; ALPHA-DEFENSINS; CASE-CONTROL STUDIES; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

MLCS; MLOWN;

EID: 84874996080     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-012-1305-0     Document Type: Article

References (16)

1. Albrethsen J, Bogebo R, Gammeltoft S, Olsen J, Winther B, Raskov H (2005) Up-regulated expression of human neutrophil peptides 1, 2, and 3 in colon cancer serum and tumors: a biomarker study. BMC Cancer 5:1-10
2. Balk SP, Ko YJ, Bubley GJ (2003) Biology of prostate-specific antigen. J Clin Oncol 21:383-391
3. Balkwill F, Mantovani A (2001) Inflammation and cancer. Lancet 357(9255):539-545
4. Bateman A, Singh A, Jothy S, Fraser R, Esch F, Solomon S (1992) The levels of biologic action of the human granule peptide HNP 1-3 in lung tumors. Peptides 13(1):133-139
5. Jan MS, Huang YH, Shieh B, Teng RH, Yan YP, Lee YT, Liao KK, Li C (2006) CC chemokines induce neutrophils to chemotaxis, degranulation, and alpha-defensin release. Acquir Immune Defic Syndr 41:6-16
6. Kemik O, Kemik AS, Sumer A, Begenik H, Purisa S, Tuzun S (2011) Human neutrophil peptides -1, -2, and -3 (HNP 1-3): elevated serum levels in colorectal cancer and novel marker of lymphatic and hepatic metastases. Hum Exp Toxicol PMID:21669914
7. Koss LG, Deitch D, Ramathan R, Sherman AB (1985) Diagnostic value of cytology of voided urine. Acta Cytol 29(5):810-816
8. Lapham RL, Ro JY, Staerkel GA, Ayala AG (1997) Pathology of transitional cell carcinoma of the bladder and its clinical implications. Semin Surg Oncol 13:307-318
9. Linzmeier R, Ho CH, Hoang BV, Ganz T (1999) A 450-kb contig of defensin genes on human chromosome 8p23. Gene 233:205-211
10. Lundy FT, Orr DF, Gallagher JR, Maxwell P, Shaw C, Napier SS, Gerald C, Lamey PJ, Marley JJ (2004) Identification and overexpression of HNP 1-3 in squamous cell carcinomas of the human tongue. Oral Oncol 40(2):139-144
11. MIsuno NI, Kolesnikova TS, Lerer RI, Gants T, Voitenok NN (1992) Effects of human defensin HNP 1-3 on the production of tumor necrosis factor-alpha by human blood monocytes in vitro. Biull Eksp Biol Med 113(5):524-527
12. Muller CA, Markovic-Lipkovski J, Gamper J, Schwarz G, Beck H, Deeg M, Kalbacher H, Widmann S, Wessels JT, Becker V, Muller GA, Flad T (2002) HNP 1-3 in renal cell carcinoma; influences on tumor cell proliferation. Am J Pathol 160(4):1311-1324
13. Quellette AJ, Pravtcheva D, Ruddle FH, James M (1989) Localization of the cryptdin locus on mouse chromosome 8. Genomics 5:233-239
14. Sharma S, Ksheersagar P, Sharma P (2009) Diagnosis and treatment of bladder cancer. Am Fam Physician 80(7):717-723
15. Van Kempen LC, Ruiter DJ, van Muijen GN, Coussens LM (2003) The tumor microenvironment: a critical determinant of neoplastic evolution. Eur J Cell Biol 82(11):539-554
16. Vlahou A, Schellhammer PF, Mendrinos S, Patel K, Kondlysis FI, Gong L, Nasim S, Wright GLJ Jr (2001) Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine. Am J Pathol 158(4):1491-1501